tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Lee, 80 are a BUY (88.89%), 10 are a HOLD (11.11%).
Analyst Sean Lee, carries an average stock price target met ratio of 30.9% that have a potential upside of 43.45% achieved within 140 days. Previously, Sean Lee worked at HCWAINWRIGHT.
Sean Lee’s has documented 168 price targets and ratings displayed on 16 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRVS, Corvus Pharmaceuticals at 20-Jan-2026.
Analyst best performing recommendations are on MNPR (MONOPAR THERAPEUTICS).
The best stock recommendation documented was for MNPR (MONOPAR THERAPEUTICS) at 1/22/2025. The price target of $40 was fulfilled within 2 days with a profit of $6.33 (18.8%) receiving and performance score of 94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-May-2023
$4
$2.98 (292.16%)
$4
5 months 11 days ago
(03-Sep-2025)
1/7 (14.29%)
$1.67 (71.67%)
54
Buy Since 17-May-2021
$4
3 years 2 months 29 days ago
(16-Nov-2022)
1/2 (50%)
$0.72 (21.95%)
73
Buy Since 24-Mar-2020
$12
$10.98 (1076.47%)
3 years 5 months 30 days ago
(15-Aug-2022)
1/2 (50%)
$7.98 (198.51%)
308
Buy
$50
3 years 8 months 20 days ago
(26-May-2022)
0/1 (0%)
$32.3 (182.49%)
Which stock is Sean Lee is most bullish on?
Which stock is Sean Lee is most reserved on?
What Year was the first public recommendation made by Sean Lee?
